• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

EUSA Pharma - Articles and news items

MAA submitted for tivozanib for the treatment of RCC

Industry news / 1 March 2016 / Victoria White

Tivozanib is an oral, once-daily, vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI)…

 

Webinar: SIFT-MS: A New Tool for Impurity Profiling in Pharmaceutical ProductsLEARN MORE
+ +